For the quarter ended March 2026, Natera (NTRA Quick QuoteNTRA - Free Report) reported revenue of $696.64 million, up 38.8% over the same period last year. EPS came in at -$0.56, compared to -$0.50 in the year-ago quarter.

The reported revenue represents a surprise of +13.26% over the Zacks Consensus Estimate of $615.11 million. With the consensus EPS estimate being -$0.53, the EPS surprise was -5.26%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Natera performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Volume - Tests processed: 1,013,600 versus 959,038 estimated by three analysts on average.
• Volume - Tests reported in our laboratory: 918,100 compared to the 918,948 average estimate based on two analysts.
• Revenues- Product: $693.87 million compared to the $610.89 million average estimate based on four analysts. The reported number represents a change of +38.8% year over year.
• Revenues- Licensing and other: $2.78 million compared to the $1.95 million average estimate based on four analysts. The reported number represents a change of +54.7% year over year.

View all Key Company Metrics for Natera here>>>

Shares of Natera have returned +2% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.